2026 NPPES data Medical Oncology Physician NPI 1083659163 MD
Verify on CMS →

MICHEL KUZUR, MD

Medical Oncology Physician in NASHVILLE, Tennessee. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
735
Medicare Part D claims · 110 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.6K
55 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHEL KUZUR, MD is a Medical Oncology Physician ([object Object]) practicing in NASHVILLE, Tennessee with a Medicare Part D prescribing footprint of 735 claims across 110 beneficiaries — 18% brand-name prescribing . Industry payments of $2.6K across 55 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHEL KUZUR, MD filed 735 Medicare Part D claims in 2023 across NASHVILLE, Tennessee. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MICHEL KUZUR, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MICHEL KUZUR, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 06/20/2006

NPI 1083659163

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

735 7% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Tennessee

How Medical Oncology Physician compares to other specialties among Tennessee providers

Tennessee providers

Medical Oncology Physician share within Tennessee

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Tennessee

Specialty board-certification context

Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Medical Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHEL KUZUR, MD is a Medical Oncology Physician provider practicing in NASHVILLE, Tennessee, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1083659163. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHEL KUZUR, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 3443 DICKERSON PIKE, NASHVILLE, TN, 37207, with a listed phone of (615) 860-1556. NPI 1083659163 was issued on 06/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KUZUR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 735 prescription claims written by this provider, covering 110 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 6.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3443 DICKERSON PIKE
NASHVILLE, TN 37207

Provider Details

NPI 1083659163
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 06/20/2006

Hospital and facility affiliations

Facilities where MICHEL KUZUR, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TENNESSEE ONCOLOGY PLLC
TULLAHOMA, TN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHEL KUZUR, MD. Source: openpaymentsdata.cms.gov.

Total received

$2.6K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MICHEL KUZUR, MD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 735 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

735
Total Claims
$1.1M
Total Drug Cost
110
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,216
Total Day Supply
33,471
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$32K
Opioid Claims
47 (6.4% rate)
Antibiotic Claims
21

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
2.13
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Anastrozole
76
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
36
Hydroxyurea
33
Prochlorperazine Maleate
29
Eliquis
Apixaban
25
Warfarin Sodium
24
Imbruvica
Ibrutinib
23
Calquence
Acalabrutinib Maleate
21
Prednisone
18
Dexamethasone
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MICHEL KUZUR, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MICHEL KUZUR, MD's 735 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Tennessee

Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as KUZUR.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHEL KUZUR, MD's specialty?
MICHEL KUZUR, MD specializes in Medical Oncology Physician and practices in NASHVILLE, Tennessee. Credentials: MD.
How much does MICHEL KUZUR, MD prescribe under Medicare Part D?
In 2023, MICHEL KUZUR, MD wrote 735 Medicare Part D claims totaling $1.1M in drug costs for 110 beneficiaries.
Where is MICHEL KUZUR, MD located?
MICHEL KUZUR, MD is located at 3443 DICKERSON PIKE, NASHVILLE, TN, 37207. Phone: (615) 860-1556.
What is MICHEL KUZUR, MD's NPI number?
MICHEL KUZUR, MD's National Provider Identifier (NPI) is 1083659163, issued on 06/20/2006.
Does MICHEL KUZUR, MD prescribe more brand-name or generic drugs?
MICHEL KUZUR, MD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $1.1M in brand drug costs.
Does MICHEL KUZUR, MD prescribe opioids?
Yes, MICHEL KUZUR, MD had 47 opioid claims in 2023 with an opioid prescribing rate of 6.4%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MICHEL KUZUR, MD prescribe most often?
Based on 2023 Medicare Part D data, MICHEL KUZUR, MD's most frequently prescribed drugs include Anastrozole, Hydrocodone-Acetaminophen, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHEL KUZUR, MD accept Medicare?
MICHEL KUZUR, MD appears in CMS Medicare data with 735 Part D claims and 110 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHEL KUZUR, MD's credentials?
MICHEL KUZUR, MD's NPI is 1083659163 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology